Over the course of two months, a multinational team used Sysrev to assess the clinical characteristics and the risk factors associated with SARS CoV2 in patients with Chronic Kidney Disease.
We built the sysrev.com platform for reviewing documents in teams and launched it last summer. Over the last two months, a team from the UK and China used the platform to collect evidence on COVID19 in patients with chronic kidney disease.
The linked blog post goes into some of the detail about how Dr. Keenan's team used sysrev. I can't wait to see some of the conclusions they draw from the research, all of the evidence for which is available in open access sysrev projects.
If you're interested in analyzing the data they collected see https://sysrev.com/u/249/p/29629. If you like the idea of open access research and want to help analyze other projects please ping me!
1 comment
[ 368 ms ] story [ 127 ms ] threadWe built the sysrev.com platform for reviewing documents in teams and launched it last summer. Over the last two months, a team from the UK and China used the platform to collect evidence on COVID19 in patients with chronic kidney disease.
The linked blog post goes into some of the detail about how Dr. Keenan's team used sysrev. I can't wait to see some of the conclusions they draw from the research, all of the evidence for which is available in open access sysrev projects.
If you're interested in analyzing the data they collected see https://sysrev.com/u/249/p/29629. If you like the idea of open access research and want to help analyze other projects please ping me!